Sponsor Dossier
Swedish Orphan Biovitrum
Sponsor Dossier for Swedish Orphan Biovitrum. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: DOPTELET
- Brand: EMPAVELI
- Brand: KINERET
- Brand: ZYNLONTA
- Device (sponsor): Mechanically-operated infusion pump set
- Device (sponsor): Mechanically-operated infusion pump
About
Swedish Orphan Biovitrum is an Australian Private Company with ABN 14 645 396 532, registered in NSW and currently active.
Portfolio
Swedish Orphan Biovitrum has 4 brands on the ARTG, of which 4 are indexable and 4 carry a Product Information document. 3 brands are PBS-listed, 4 have a PBAC outcome on record, and 3 have an AusPAR on record. Notable brands include DOPTELET, EMPAVELI, KINERET, ZYNLONTA.
Therapeutic focus
— Immunology: 1 brand — Oncology: 1 brand — Rare Disease: 1 brand — Haematology: 1 brand
PBS footprint
3 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-07-01, across 4 brands with a PBAC outcome on record. The latest AusPAR is 2026-06-16, across 3 brands with an AusPAR on record.